cro.directory
← Home
Sussex Research Laboratories Inc. logo

Sussex Research Laboratories Inc.

Global leader in carbohydrate synthesis and glycoscience CRO/CDMO services.

Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise. Headquartered in Canada.

Phases

Indications / Therapeutic Areas

Services

Modalities

About this organization

Overview

Sussex Research Laboratories Inc. is a specialized contract research organization (CRO) and contract development & manufacturing organization (CDMO) focused on glycoscience and carbohydrate chemistry. The company serves as a global leader in carbohydrate synthesis, glycan design, and glycoconjugate development.

Core Capabilities

Glycan Synthesis & Design

  • Custom carbohydrate synthesis tailored to specific project requirements
  • Expertise in scalable, cost-effective synthesis methods
  • Specialization in GalNAc targeting ligands and hepatic/extra-hepatic drug delivery strategies
  • Production of complex oligosaccharides and modified monosaccharide scaffolds

Glycopeptides & Peptides

  • Over 20 years of glycopeptide synthesis expertise
  • World's largest inventory of well-defined glycoamino acid building blocks
  • Synthesis of tumor-associated carbohydrate antigens (TACA), PSGL-1 mimetics, and glycopolypeptides
  • Capabilities in glycated, glycolipid, lipid, and macrocyclic peptides

Antibody Development

  • Production of carbohydrate-based antigens for antibody screening and production
  • Synthesis of glycan, glycopeptide, and glycolipid antigens with carrier protein conjugates (BSA, OVA, CRM, KLH)

Targeting Ligands

  • Cell-specific carbohydrate ligands targeting ASGPR, Galectins, Siglecs, and other carbohydrate-binding protein receptors
  • Lectin-mediated drug delivery solutions for challenging therapeutic molecules including RNA

Product Portfolio

  • Extensive catalog of glycans, glycoamino acids, glycopeptides, glycan probes, and pharmaceutical standards
  • Liquid Glycan Array (LiGA) platform for high-throughput glycan-based targeting discovery
  • Neo-glycoprotein conjugates, lipopolysaccharides, and stable isotope standards

Service Model

Comprehensive project lifecycle support from initial consultation through post-delivery technical support, including:

  • Feasibility assessments and bespoke proposals
  • Research and development with regular progress updates
  • Rigorous quality control and Certificate of Analysis documentation
  • Connections to trusted network for pre-clinical and GMP manufacturing scale-up

Company Profile

  • Founded: Over 25 years of industry experience
  • Certifications: ISO 9001:2015 certified
  • Client Base: 1000+ clients worldwide
  • Manufacturing: Made in Canada with international recognition
  • Applications: Vaccines, targeted drug delivery systems, therapeutic antibodies, diagnostics, and novel glycan-based therapeutics

Certifications

AuthorityIdentifierSource
ISOISO 9001:2015View

Locations

  • Headquarters

    Canada

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/sussex-research.md